The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 01, 2018
Filed:
Dec. 19, 2012
Applicant:
GE Healthcare Limited, Little Chalfont, GB;
Inventors:
Grethe Tang Dalsgaard, Amersham, GB;
Ian Andrew Wilson, Amersham, GB;
Assignee:
GE HEALTHCARE LIMITED, , GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); C07K 14/475 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); A61K 51/08 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0004 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 51/08 (2013.01); C07K 14/4753 (2013.01); C07K 16/2863 (2013.01); G01N 33/5017 (2013.01); G01N 33/574 (2013.01); G01N 33/57423 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to methods useful in the selection of cancer patients suitable for treatment with therapies directed at c-Met. The method employs imaging agents which compriseF-radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. Also disclosed are methods of treatment, methods of monitoring therapy directed atc-Met and the use of the imaging agents and peptides in the methods of the invention.